Evidence map›Paper›PMID 31354024›Full record

ArticleCell cycle (Georgetown, Tex.)2019

LncRNA HIF1A-AS1 contributes to ventricular remodeling after myocardial ischemia/reperfusion injury by adsorption of microRNA-204 to regulating SOCS2 expression.

Xiang Xue, Libo Luo

RetractedOpen access · bronzeAbstract readRetracted Publication
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 45 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. The Effect ofPharmacogenomics and personalized medicine · 2022
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Long Noncoding RNAs in Myocardial Ischemia-Reperfusion Injury.Oxidative medicine and cellular longevity · 2021
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Xiang XueCardiovascular Medicine Department, Changzhou No.7 People' s Hospital , Changzhou , Jiangsu , China.
Libo LuoCardiovascular Medicine Department, Changzhou No.7 People' s Hospital , Changzhou , Jiangsu , China.ORCID https://orcid.org/0000-0002-0681-8589
Changzhou No.2 People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsApoptosisCreatine KinaseCytokinesDisease Models, AnimalGene Expression RegulationHeart VentriclesHypoxia-Inducible Factor 1, alpha SubunitL-Lactate DehydrogenaseMiceMice, Inbred C57BLMicroRNAsMicroscopy, Electron, TransmissionMyocardial Reperfusion InjuryMyocardiumMyocytes, Cardiacbrain natriuretic peptide receptorCreatine KinaseCytokinesHif1a protein, mouseHypoxia-Inducible Factor 1, alpha SubunitL-Lactate DehydrogenaseMicroRNAsMIRN204 microRNA, mouseMyosin Heavy ChainsNonmuscle Myosin Type IIBnonmuscle myosin type IIB heavy chainReceptors, Atrial Natriuretic FactorRNA, Long NoncodingSocs2 protein, mouseSuppressor of Cytokine Signaling ProteinsTroponin TLncRNA HIF1A-AS1microRNA-204SOCS2

Identifiers

PMID31354024
PMCPMC6739046
OpenAlexW2965451205

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.